Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 713.4	$ 617.9
Accounts receivable, less allowance for doubtful accounts	1,064.5	1,363.9
Inventories	2,496.5	2,385.0
Prepaid expenses and other current assets	432.4	357.1
Total Current Assets	4,706.8	4,723.9
Property, plant and equipment, net	2,056.5	2,077.4
Goodwill	8,982.4	9,599.7
Intangible assets, net	6,937.4	7,257.6
Other assets	964.5	980.1
Total Assets	23,647.6	24,638.7
Current Liabilities:
Accounts payable	363.4	400.9
Income taxes payable	121.9	126.7
Salaries, wages and benefits	214.7	314.1
Other current liabilities	1,011.2	1,099.8
Current portion of long-term debt	450.0	1,500.0
Total Current Liabilities	2,161.2	3,441.5
Deferred income taxes, net	804.9	840.1
Long-term income tax payable	689.4	685.1
Other long-term liabilities	588.9	557.8
Long-term debt	7,759.3	6,721.4
Total Liabilities	12,003.7	12,245.9
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 310.7 million shares in 2020 (309.9 million in 2019) issued	3.1	3.1
Paid-in capital	9,014.0	8,920.1
Retained earnings	9,610.0	10,427.3
Accumulated other comprehensive loss	(265.8)	(241.9)
Treasury stock, 103.8 million shares in 2020 (103.9 million shares in 2019)	(6,719.9)	(6,720.5)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	11,641.4	12,388.1
Noncontrolling interest	2.5	4.7
Total Stockholders' Equity	11,643.9	12,392.8
Total Liabilities and Stockholders' Equity	$ 23,647.6	$ 24,638.7